论文部分内容阅读
对52例2型糖尿病(T2DM)合并甲状腺疾病患者的临床资料进行分析、总结。结果T2DM合并甲亢患者16例继续胰岛素治疗,11例改用口服药物,1例停用所有药物;T2DM合并甲减患者14例继续应用胰岛素治疗,2例改用口服药物;T2DM合并亚甲炎患者1例继续胰岛素治疗,5例改用口服药物,2例停用所有降糖药物。认为T2DM、甲状腺疾病有共同的遗传免疫学基础,关系密切,症状常叠加且相互影响,故两者合并应两病兼治,治疗中应注意血糖的控制及甲状腺功能的改善。
52 cases of type 2 diabetes mellitus (T2DM) with thyroid disease in patients with clinical data analysis and summary. Results 16 patients with T2DM complicated with hyperthyroidism continued insulin therapy, 11 patients switched to oral medication, and 1 patient discontinued all drugs. 14 patients with T2DM complicated with hypothyroidism continued to receive insulin therapy and 2 patients switched to oral medication. Patients with T2DM complicated with methylene- One patient continued insulin therapy, five switched to oral medication, and two discontinued all antidiabetic drugs. T2DM, thyroid disease that have a common basis of genetic immunology, closely related to the symptoms often superimposed and affect each other, so the two should be combined with both disease and treatment, treatment should pay attention to the control of blood glucose and thyroid function improved.